Work

Supplementary Table S2 from A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti–CTLA-4 Antibody) and Balstilimab (Anti–PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas

Year: 2025

Type: supplementary-materials

Abstract: Complete clinical and genetic details of patients

DOI: 10.1158/1078-0432.29567932

Authors: Breelyn A. Wilky, Katherine A. Julian, Alessandra Maleddu, Anne C. Mailhot, Chelsey R. Cartwright, Dexiang Gao, Cristiam Moreno Tellez, Lindsey E. Kemp, Nicholas R. Therrien, Sumra S. Chaudhry, Jeffrey D. Rytlewski, Qierra R. Brockman, Eduardo Davila, Anthony D. Elias

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4412417544

Cites:

Cited by:

Related to: 10